New Brunswick is changing how cervical cancer screening is done, with HPV testing replacing the traditional Pap test as the province’s primary screening method.
The provincial government announced the transition on November 18, saying the new approach will help identify people at risk of cervical cancer before abnormal cell changes develop.
Unlike Pap tests, which look for abnormal cells, HPV testing detects the virus responsible for cervical cancer. Finding the virus earlier gives health-care providers an opportunity to recommend followup care before those changes occur.
“The research is clear: early detection of cancer can help save lives,” said Health Minister John Dornan. “By transitioning to HPV testing, we are improving our ability to identify individuals at risk of cervical cancer earlier, which is essential for prevention.”
Who Should Get Tested and How Often?
Under the province’s screening recommendations, women, trans men and gender-diverse people aged 25 to 69 who have a cervix and have ever been sexually active should receive an HPV test every five years.
If you fall within this group, the government encourages you to continue regular screening through your primary health-care provider. You can also discuss your individual screening needs with your provider.
One important distinction is that a positive HPV test does not mean you have cervical cancer. Depending on your results, your health-care provider may recommend further testing or followup.
Dr. Eshwar Kumar, medical officer at the New Brunswick Cancer Network, said the change will help identify high-risk individuals sooner and allow preventive care to begin earlier.
At-Home HPV Testing Planned for 2027
Another change is in development. New Brunswick is working on an at-home HPV self-sampling option for cervical cancer screening, with implementation expected in 2027.
The province’s transition also forms part of a broader effort to eliminate cervical cancer. The World Health Organization has established a worldwide elimination goal, while Canada’s federal action plan targets eliminating the disease by 2040.
Provinces and territories are working together on the transition, although each is at a different stage of introducing HPV testing.
Andrea Seale, CEO of the Canadian Cancer Society, welcomed New Brunswick’s decision, calling it “meaningful progress for New Brunswickers.” She also linked the change to Canada’s commitment, reaffirmed through the G7, to eliminate cervical cancer.
More Information: Screening for cervical cancer









